Buch, Englisch, 354 Seiten, Book, Format (B × H): 148 mm x 210 mm, Gewicht: 491 g
What Can Germany Learn from the USA
Buch, Englisch, 354 Seiten, Book, Format (B × H): 148 mm x 210 mm, Gewicht: 491 g
Reihe: Gesundheitsmanagement und Gesundheitsökonomik
ISBN: 978-3-658-27842-7
Verlag: Springer
Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
- Wirtschaftswissenschaften Volkswirtschaftslehre Gesundheitsökonomie
- Wirtschaftswissenschaften Betriebswirtschaft Management Forschung & Entwicklung (F&E), Innovation
Weitere Infos & Material
Personalized Medicine Background.- The United States of America as Early Knower.- Germany as Follower.- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.
